Samsung Bioepis Racks Up More Awards for Its Biosimilar Packaging

Tony Hagen

Tony Hagen is senior managing editor for The Center for Biosimilars®.

Medicinal packaging shouldn't remind patients that they have a condition, according to Samsung Bioepis.

Medicinal packaging doesn’t have to be harsh and strident. That’s the concept behind the biosimilar packaging for which Samsung Bioepis continues to earn international awards. Most recently, Samsung Bioepis has garnered International Forum (iF) Design Award 2021 honors for packaging.

Soft shapes and soothing mono-colors characterize the package designs for Samsung Bioepis’ drug products, which include biosimilars. The company, based in Incheon, Republic of Korea, has called its package design concept “Passion for Health—Pure Joy in Life.”

“Taking medication can be a constant reminder of the medical condition, and we wanted to remind patients of ‘pure joy’ in life when they look at our product packaging and design,” Jaywoo Kim, senior vice president and manufacturing division leader at Samsung Bioepis, said in a statement.

The company won in 2 categories: Packaging—Medicine/Pharmaceutics and Communication—Corporate Identity/Branding.

In 2020, the company won package design awards in the Red Dot competition.